# Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-tolerability-and-safety-of-eptinezumab-in-patients-with-a-dual/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hans‐Christoph Diener,Michael J. Marmura,Stewart J. Tepper,Robert P. Cowan,Amaal J. Starling,Merle L. Diamond,Joe Hirman,Lahar Mehta,Thomas Brevig,Bjørn Sperling,Roger Cady |
| Citations | 102 |
| DOI | 10.1111/head.14036 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/head.14036 |
| OpenAlex ID | https://openalex.org/W3111843559 |
| PMID | 33314079 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Robert P. Cowan](https://scholariq.org/researchers/robert-p-cowan/)

## Paper journal

- [Headache The Journal of Head and Face Pain](https://scholariq.org/journals/headache-the-journal-of-head-and-face-pain/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Cerebrovascular and genetic disorders](https://scholariq.org/topics/cerebrovascular-and-genetic-disorders/)
- [S100 Proteins and Annexins](https://scholariq.org/topics/s100-proteins-and-annexins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.